Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

Clinical trial NCT01404962 · COMPLETED

Trial details

NCT number: NCT01404962
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Haemophilus Influenzae Type B Infection

Start date: 2011-08-01
Primary completion: 2012-07-01
Enrollment: 764

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.